封面
市场调查报告书
商品编码
1540797

2024-2032 年按分析类型、组件类型、技术、应用、最终用户(临床诊断实验室、研究组织等)和地区分類的蛋白质组学市场报告

Proteomics Market Report by Analysis Type, Component Type, Technology, Application, End-User (Clinical Diagnostic Laboratories, Research Organizations, and Others), and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2023年全球蛋白质体IMARC Group规模达363亿美元。

蛋白质体学是指大规模研究蛋白质体、其结构和生理功能。 1994 年,马克·威尔金斯 (Mark Wilkins) 首次为从基因组翻译而来的蛋白质创造了术语“蛋白质组”,以表示在活生物体中合成的整套蛋白质。它涵盖了现有蛋白质在暴露于不同条件下时所发生的修饰和变化。蛋白质体学应用各种技术来定量和鑑定蛋白质,以及检测诊断标记、了解细胞中的病原体以及解释不同疾病中的蛋白质途径。它还评估蛋白质产生的速率和蛋白质的相互作用模式,因此它在药物发现和个人化药物的开发中具有广泛的适用性。

对个人化药物的日益青睐,以及药物发现和生物技术研究和开发的不断增加,是推动市场成长的关键因素。蛋白质组系统减少了药物化学合成和生物测试所需的时间、成本和资源,并简化了药物发现过程。此外,与生物标记识别和基于质谱的蛋白质组学相关的机会进一步有利于市场成长。此外,蛋白质综合分析技术的技术渗透率不断提高,也推动了市场的发展。这些技术包括电喷雾电离-液相层析-质谱(ESI-LC-MS)、表面等离子体共振、微阵列、蛋白质分级分离系统和X射线晶体学。这些进步使得能够对蛋白质进行彻底的定量和定性分析以及癌症疗法和治疗方法的鑑定。其他因素,例如政府对广泛研发(R&D)的有利政策,也促进了市场的成长。

本报告回答的关键问题

  • 全球蛋白质体学市场有多大? 2024-2032年全球蛋白质体学市场的预期成长率是多少?
  • 推动全球蛋白质体学市场的关键因素是什么?
  • COVID-19 对全球蛋白质体学市场有何影响?
  • 基于该技术的全球蛋白质体学市场的细分情况如何?
  • 基于最终用户的全球蛋白质体学市场的划分是怎样的?
  • 全球蛋白质体学市场的关键区域有哪些?
  • 谁是全球蛋白质体学市场的主要参与者/公司?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球蛋白质体学市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章:市场区隔:按分析类型

  • 结构蛋白质体学
    • 市场趋势
    • 市场预测
  • 功能蛋白质体学
    • 市场趋势
    • 市场预测
  • 蛋白质表现蛋白质体学
    • 市场趋势
    • 市场预测

第 7 章:市场区隔:按组件类型

  • 核心蛋白质体学服务
    • 市场趋势
    • 市场预测
  • 生物资讯软体及相关服务
    • 市场趋势
    • 市场预测

第 8 章:市场区隔:依技术

  • 光谱学
    • 市场趋势
    • 市场预测
  • 色谱法
    • 市场趋势
    • 市场预测
  • 电泳
    • 市场趋势
    • 市场预测
  • 蛋白质微阵列
    • 市场趋势
    • 市场预测
  • X射线晶体学
    • 市场趋势
    • 市场预测
  • 表面等离子共振
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章:市场区隔:按应用

  • 蛋白质表现谱
    • 市场趋势
    • 市场预测
  • 蛋白质体挖掘
    • 市场趋势
    • 市场预测
  • 翻译后修饰
    • 市场趋势
    • 市场预测

第 10 章:市场区隔:依最终用户

  • 临床诊断实验室
    • 市场趋势
    • 市场预测
  • 研究组织(药物发现)
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 11 章:市场区隔:按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分:按国家/地区
    • 市场预测

第 12 章:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章:价值链分析

第 14 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第15章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Bio-RAD Laboratories Inc.
    • Bruker Corporation
    • Creative Proteomics
    • Danaher Corporation
    • GE Healthcare Inc.
    • Horiba Ltd.
    • Luminex Corporation
    • Merck Group
    • Perkinelmer Inc.
    • Promega Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112024A2156

The global proteomics market size reached US$ 36.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 126.2 Billion by 2032, exhibiting a growth rate (CAGR) of 14.4% during 2024-2032.

Proteomics refers to the study of proteomes, their structure and physiological functions on a large-scale. In 1994, Mark Wilkins first coined the term proteome for the proteins that are translated from genome, to denote the whole set of proteins synthesized within a living organism. It encompasses the modifications and alterations that take place in the existing protein when it is exposed to varying conditions. Proteomics applies various technologies for the quantification and identification of proteins, along with the detection of diagnostic markers, understanding of pathogens in cells and interpretation of protein pathways in different diseases. It also evaluates the rate of protein production and the interaction patterns of proteins due to which it finds extensive applicability in drug discovery and the development of personalized medications.

The growing preference for personalized drugs, along with increasing research and development in drug discovery and biotechnology, is the key factor driving the growth of the market. Proteomic systems reduce the time, cost and resources needed for the chemical synthesis and biological testing of drugs and simplify the process of drug discovery. Furthermore, opportunities related to biomarker identification and mass spectrometry-based proteomics are favoring the market growth further. Additionally, the market is driven by increasing technological penetration in the comprehensive analysis of protein techniques. These techniques include Electrospray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS), surface plasma resonance, microarray, protein fractionation systems and X-ray crystallography. These advancements enable a thorough quantitative and qualitative analysis of proteins and identification of cancer therapies and treatments. Other factors, such as favorable government policies for extensive research and development (R&D) are also augmenting the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global proteomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on analysis type, component type, technology, application and end-user.

Breakup by Analysis Type:

Structural Proteomics

Functional Proteomics

Protein Expression Proteomics

Breakup by Component Type:

Core Proteomics Services

Bioinformatics Software and Related Services

Breakup by Technology:

Spectroscopy

Chromatography

Electrophoresis

Protein Microarrays

X-Ray Crystallography

Surface Plasmon Resonance

Others

Breakup by Application:

Protein Expression Profiling

Proteome Mining

Post-translational Modifications

Breakup by End-User:

Clinical Diagnostic Laboratories

Research Organizations (Drug Discovery)

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report

  • 1. How big is the global proteomics market?
  • 2. What is the expected growth rate of the global proteomics market during 2024-2032?
  • 3. What are the key factors driving the global proteomics market?
  • 4. What has been the impact of COVID-19 on the global proteomics market?
  • 5. What is the breakup of the global proteomics market based on the technology?
  • 6. What is the breakup of the global proteomics market based on the end-user?
  • 7. What are the key regions in the global proteomics market?
  • 8. Who are the key players/companies in the global proteomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Proteomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Analysis Type

  • 6.1 Structural Proteomics
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Functional Proteomics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Protein Expression Proteomics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Component Type

  • 7.1 Core Proteomics Services
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics Software and Related Services
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Spectroscopy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Chromatography
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Electrophoresis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Protein Microarrays
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 X-Ray Crystallography
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Surface Plasmon Resonance
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Protein Expression Profiling
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Proteome Mining
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Post-translational Modifications
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Clinical Diagnostic Laboratories
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research Organizations (Drug Discovery)
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bio-RAD Laboratories Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bruker Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Creative Proteomics
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 GE Healthcare Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Horiba Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Luminex Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Merck Group
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Perkinelmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Promega Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Waters Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Proteomics Market: Major Drivers and Challenges
  • Figure 2: Global: Proteomics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Proteomics Market: Breakup by Analysis Type (in %), 2023
  • Figure 4: Global: Proteomics Market: Breakup by Component Type (in %), 2023
  • Figure 5: Global: Proteomics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Proteomics Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Proteomics Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Proteomics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Proteomics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Proteomics (Structural Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Proteomics (Structural Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Proteomics (Functional Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Proteomics (Functional Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Proteomics (Protein Expression Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Proteomics (Protein Expression Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Proteomics (Core Proteomics Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Proteomics (Core Proteomics Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Proteomics (Bioinformatics Software and Related Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Proteomics (Bioinformatics Software and Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Proteomics (Spectroscopy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Proteomics (Spectroscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Proteomics (Chromatography) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Proteomics (Chromatography) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Proteomics (Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Proteomics (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Proteomics (Protein Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Proteomics (Protein Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Proteomics (X-Ray Crystallography) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Proteomics (X-Ray Crystallography) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Proteomics (Surface Plasmon Resonance) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Proteomics (Surface Plasmon Resonance) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Proteomics (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Proteomics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Proteomics (Protein Expression Profiling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Proteomics (Protein Expression Profiling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Proteomics (Proteome Mining) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Proteomics (Proteome Mining) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Proteomics (Post-translational Modifications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Proteomics (Post-translational Modifications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Proteomics (Clinical Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Proteomics (Clinical Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Proteomics (Research Organizations-Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Proteomics (Research Organizations-Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Proteomics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Proteomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: North America: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: North America: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: United States: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: United States: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Canada: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Canada: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Asia Pacific: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Asia Pacific: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: China: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: China: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Japan: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Japan: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: India: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: India: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: South Korea: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: South Korea: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Australia: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Australia: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Indonesia: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Indonesia: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Europe: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Europe: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Germany: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Germany: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: France: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: France: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: United Kingdom: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: United Kingdom: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Italy: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Italy: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Spain: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Spain: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Russia: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Russia: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Latin America: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Latin America: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Brazil: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Brazil: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Mexico: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Mexico: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Others: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Middle East and Africa: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Middle East and Africa: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Global: Proteomics Industry: SWOT Analysis
  • Figure 95: Global: Proteomics Industry: Value Chain Analysis
  • Figure 96: Global: Proteomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Proteomics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Proteomics Market Forecast: Breakup by Analysis Type (in Million US$), 2024-2032
  • Table 3: Global: Proteomics Market Forecast: Breakup by Component Type (in Million US$), 2024-2032
  • Table 4: Global: Proteomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Proteomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Proteomics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Proteomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Proteomics Market Structure
  • Table 9: Global: Proteomics Market: Key Players